Portfolio Holdings

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Home > Funds > CF Woodford Equity Income Fund > Portfolio Holdings

We recognise that openness and transparency are key in building client understanding and we ensure that our clients get unprecedented levels of clear and relevant information about their investments, including unparalleled access to our Investment team and transparency into our portfolio construction.

To keep our investors informed, we are committed to providing full disclosure of the CF Woodford Equity Income Fund’s holdings on a monthly basis.

Please find the portfolio holdings as at 31 October 2017 below.

The details set out are for information purposes only. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed and the portfolio may change at any time. This does not constitute investment advice or any recommendation with regard to the listed stocks.

Register now to receive Portfolio disclosure alerts by email.

CF Woodford Equity Income Fund As at 31 October 2017
  Name Industry % (weight)
1 AstraZeneca Health Care 8.29
2 Imperial Brands Consumer Goods 6.19
3 Legal & General Financials 5.11
4 Prothena Health Care 3.81
5 Lloyds Financials 3.35
6 Burford Capital Financials 3.32
7 Barratt Developments  Consumer Goods 2.70
8 Purplebricks Financials 2.25
9 Provident Financial Financials 2.24
10 Taylor Wimpey  Consumer Goods 2.17
11 NewRiver REIT  Financials 2.10
12 Babcock International Industrials 2.06
13 Stobart Industrials 2.06
14 Theravance Biopharma Health Care 2.00
15 Benevolent AI (unquoted) Technology 1.89
16 Next Consumer Services 1.85
17 BCA Marketplace Industrials 1.72
18 BTG Health Care 1.71
19 Homeserve Industrials 1.49
20 Alkermes Health Care 1.43
21 Spire Healthcare Health Care 1.43
22 Oxford Nanopore (unquoted) Health Care 1.26
23 Countryside Properties Consumer Goods 1.23
24 IP Group Financials 1.23
25 Touchstone Innovations Financials 1.19
26 Eddie Stobart Logistics  Industrials 1.13
27 British Land Financials 1.12
28 Capita Industrials 1.11
29 Drax Utilities 1.11
30 Forterra Industrials 1.09
31 Redde Financials 1.09
32 Raven Russia (Convertible Pref) Financials 1.08
33 Paypoint Industrials 1.05
34 G4S Industrials 1.03
35 AA Industrials 0.96
36 Allied Minds Financials 0.95
37 P2P Global Financials 0.90
38 Horizon Discovery Health Care 0.86
39 Malin Financials 0.86
40 Hostelworld Consumer Services 0.74
41 Watkin Jones Consumer Goods 0.74
42 Oakley Capital Financials 0.72
43 Phoenix Spree Deutschland Financials 0.67
44 Breedon Industrials 0.66
45 Mereo Biopharma Health Care 0.64
46 VPC Specialty Lending Financials 0.59
47 CityFibre Telecommunications 0.55
48 Draper Esprit Financials 0.55
49 Idex Technology 0.55
50 Non-Standard Finance Financials 0.55
51 4D Pharma Health Care 0.54
52 Benchmark Health Care 0.54
53 Immunocore A (unquoted) Health Care 0.54
54 Atom Bank (unquoted) Financials 0.52
55 Honeycomb Investment Trust Financials 0.52
56 Card Factory Consumer Services 0.51
57 Circassia Health Care 0.51
58 Xeros Industrials 0.45
59 Verseon Health Care 0.43
60 Arix Bioscience  Financials 0.42
61 Viamet (unquoted) Health Care 0.42
62 Thin Film Electronics Industrials 0.42
63 Raven Russia Financials 0.40
64 Eurocell Industrials 0.39
65 Softcat Technology 0.38
66 Gigaclear (unquoted) Telecommunications 0.37
67 Crystal Amber Financials 0.36
68 Evofem D (unquoted) Health Care 0.35
69 Time Out Consumer Services 0.33
70 Oxford Sciences Innovation (unquoted) Financials 0.32
71 Sirius Real Estate Financials 0.31
72 Sabina Estates Pref  (unquoted) Financials 0.30
73 Eve Sleep Consumer Goods 0.29
74 Proton Partners International (unquoted) Health Care 0.29
75 Ombu Pref (unquoted) Financials 0.24
76 Tissue Regenix Health Care 0.23
77 A J Bell (unquoted) Financials 0.22
78 Mafic (unquoted) Industrials 0.21
79 Mercia Technologies Financials 0.21
80 Cequr (unquoted) Health Care 0.20
81 Strix Industrials 0.20
82 Spin Transfer Technologies (unquoted) Technology 0.19
83 Cell Medica (unquoted) Health Care 0.17
84 Nexeon (unquoted) Industrials 0.17
85 Accelerated Digital Ventures A (unquoted) Financials 0.15
86 Vernalis Health Care 0.15
87 Abzena Health Care 0.14
88 RM2 International 9% convertible Industrials 0.14
89 AMO Pharma (unquoted) Health Care 0.13
90 Ratesetter (unquoted) Financials 0.13
91 Autolus (unquoted) Health Care 0.12
92 Kymab B Pref  (unquoted) Health Care 0.12
93 ReNeuron Health Care 0.12
94 Utilitywise Industrials 0.12
95 Drayson Technologies C (unquoted) Technology 0.10
96 Industrial Heat (unquoted) Industrials 0.10
97 Origin (unquoted) Health Care 0.10
98 Cambridge Innovation Capital (unquoted) Financials 0.09
99 Hvivo Health Care 0.09
100 Precision Biopsy (unquoted) Health Care 0.09
101 Netscientific Health Care 0.08
102 Midatech Pharma Health Care 0.07
103 Mission Therapeutics (unquoted) Health Care 0.07
104 Federated Wireless (unquoted) Technology 0.06
105 Industrial Heat A2 Pref (unquoted) Industrials 0.06
106 Immunocore (unquoted) Health Care 0.06
107 ABLS Capital (unquoted) Health Care 0.06
108 Novabiotics (unquoted) Health Care 0.06
109 Viamet (unquoted) Health Care 0.06
110 Mafic B (unquoted) Industrials 0.05
111 Sabina Estates (unquoted) Financials 0.05
112 Carrick Therapeutics (unquoted) Health Care 0.04
113 e-Therapeutics Health Care 0.04
114 Itaconix Basic Materials 0.04
115 Kymab C (unquoted) Health Care 0.04
116 RM2 International Industrials 0.04
117 Emba (unquoted) Health Care 0.03
118 Genomics (unquoted) Health Care 0.03
119 Metalysis (unquoted) Industrials 0.03
120 Northwest Biotherapeutics Health Care 0.03
121 Oxford Pharmascience Health Care 0.03
122 Synairgen Health Care 0.03
123 Halosource Reg S Industrials 0.02
124 Emba - Series 2 (unquoted) Health Care 0.01
125 Brave Bison Technology 0.01
126 Origin (convertible pref) (unquoted) Health Care 0.01
127 Origin (warrants) (unquoted) Health Care 0.01
128 Evofem (unquoted) Health Care 0.01
129 Evofem C (unquoted) Health Care 0.01

The views and opinions expressed in this report are solely those of Capital Economics and do not necessarily reflect the views of Woodford Investment Management.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2017 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement